✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Chandra Bhagat Pharma Ltd.

CBPL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹30 Cr.
P/E
35.14

Chandra Bhagat Pharma Ltd.

  • Chandra Bhagat Pharm
  • Panjon
  • Omkar Pharmachem

FAQs on Chandra Bhagat Pharma Ltd. Shareprice

Chandra Bhagat Pharm has given lower returns compared to its competitors.
Chandra Bhagat Pharm has grown at ~-42.1% over the last 1yrs while peers have grown at a median rate of -14.74%

Chandra Bhagat Pharm is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Chandra Bhagat Pharm is 35.14, while 3 year average PE is 142.
Also latest EV/EBITDA of Chandra Bhagat Pharm is 243 while 3yr average is 20.2.

View FAQ's On Business

Growth Table

  • Chandra Bhagat Pharma Ltd.
  • Panjon
  • Omkar Pharmachem

Balance Sheet

  • Chandra Bhagat Pharma Ltd.
  • Panjon
  • Omkar Pharmachem

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Chandra Bhagat Pharma Ltd.
  • Panjon
  • Omkar Pharmachem

Cash Flow

  • Chandra Bhagat Pharma Ltd.
  • Panjon
  • Omkar Pharmachem

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Chandra Bhagat Pharma Ltd.
  • Panjon
  • Omkar Pharmachem

Quarterly Results

  • Chandra Bhagat Pharma Ltd.
  • Panjon
  • Omkar Pharmachem

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Chandra Bhagat Pharma Ltd. Financials

Chandra Bhagat Pharm balance sheet is weak and might have solvency issues

The net debt of Chandra Bhagat Pharm is decreasing.
Latest net debt of Chandra Bhagat Pharm is ₹19.73 Crs as of Sep-25.
This is less than Mar-25 when it was ₹19.75 Crs.

No, profit is decreasing.
The profit of Chandra Bhagat Pharm is ₹0.62 Crs for TTM, ₹0.86 Crs for Mar 2025 and ₹1.53 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Chandra Bhagat Pharm latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech